However, interpretation remains cautious, as reproductive endpoints (ongoing pregnancy, live birth) are inconsistently reported and dosing (commonly 24 g/day), formulations (MI alone vs 40:1 MI: DCI), co-therapies, and trial quality vary widely, prompting calls for larger, standardized, phenotype-stratified studies
The challenge of rare diseases
There are three markings that you absolutely must understand in order to know if the battery is suitable for your radio-controlled vehicle
Detecting past and ongoing natural selection among ethnically Tibetan women at high altitude in Nepal
And obviously right now it's not diabetes, it's obesity
Key Points The most important facts about Melanotan I, afamelanotide and UK regulation